On Monday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) opened higher 3.47% from the last session, before settling in for the closing price of $0.71. Price fluctuations for IRWD have ranged from $0.59 to $7.19 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -3.28% over the last five years. Company’s average yearly earnings per share was noted 1644.75% at the time writing. With a float of $156.66 million, this company’s outstanding shares have now reached $161.81 million.
The firm has a total of 253 workers. Let’s measure their productivity. In terms of profitability, gross margin is 99.57%, operating margin of 27.7%, and the pretax margin is 18.86%.
Ironwood Pharmaceuticals Inc (IRWD) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Ironwood Pharmaceuticals Inc is 3.18%, while institutional ownership is 87.61%. The most recent insider transaction that took place on Feb 10 ’25, was worth 244,753. In this transaction Chief Executive Officer of this company sold 139,064 shares at a rate of $1.76, taking the stock ownership to the 1,160,634 shares. Before that another transaction happened on Feb 10 ’25, when Company’s Principal Accounting Officer sold 12,048 for $1.76, making the entire transaction worth $21,204. This insider now owns 279,655 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 1644.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 141.01% during the next five years compared to -47.49% drop over the previous five years of trading.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Check out the current performance indicators for Ironwood Pharmaceuticals Inc (IRWD). In the past quarter, the stock posted a quick ratio of 4.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.37. Likewise, its price to free cash flow for the trailing twelve months is 1.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.20, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.35 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Analysing the last 5-days average volume posted by the [Ironwood Pharmaceuticals Inc, IRWD], we can find that recorded value of 2.56 million was lower than the volume posted last year of 3.41 million. As of the previous 9 days, the stock’s Stochastic %D was 7.58%. Additionally, its Average True Range was 0.11.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 3.15%, which indicates a significant decrease from 14.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 115.23% in the past 14 days, which was lower than the 126.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1694, while its 200-day Moving Average is $3.3101. Now, the first resistance to watch is $0.7678. This is followed by the second major resistance level at $0.8018. The third major resistance level sits at $0.8247. If the price goes on to break the first support level at $0.7109, it is likely to go to the next support level at $0.6880. Now, if the price goes above the second support level, the third support stands at $0.6540.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
There are currently 161,809K shares outstanding in the company with a market cap of 118.74 million. Presently, the company’s annual sales total 351,410 K according to its annual income of 880 K. Last quarter, the company’s sales amounted to 90,550 K and its income totaled 2,260 K.
